1. Advancing excellence in vein and lymphatic care

To improve excellence in the diagnosis and treatment of venous and lymphatic disorders as long as patient-centered care focusing on improving patient outcomes.

2. World Congresses & other scientific events

To make UIP World Congress as the most prestigious global phlebology gathering and organize other live or online meetings to increase the scientific dominance of UIP.

3. Improvement of UIP's financial situation

All candidates in this group are committed to prioritize the interests of UIP in this regard. The executive committee candidates have organized many national and international congresses for many years worldwide and have huge experience. We aim to bring UIP economically strong union provided a scientific, respectful relation with phlebology world and the related industry partners.

4. Global outreach and recognition of emerging phlebology societies

To foster collaboration among 81 member societies, ensuring that UIP’s leadership reflects a diverse and inclusive perspective for addressing global challenges in phlebology.

5. Education and professional development

To elect committee members who are committed to providing access to high-quality education, training, and resources for current and future medical professionals in the field of phlebology. We aim to promote online learning platforms as webinars, case- based learning, online certification and UIP-endorsed fellowships.

6. Ethical and transparent governance

To ensure that elections and leadership structures are conducted with the highest ethical standards, transparency, and accountability.

7. International guidelines in venous and lymphatic disease

To lead International guidelines in venous and lymphatic disease as classification systems, diagnostic standards, treatment techniques, compression therapy, venous ulcer management, pelvic venous disorders and venous thromboembolism.

8. Research funding and collaboration with industry partners

To collaborate with companies like producing sclerosing agents, catheters, compression devices, ablation technologies, or phlebology imaging equipment to fund clinical trials that encourages innovation and evidence-based advancement.